Trigeminal Neuralgia
📧 Sign up to get email alerts when something new happens for Trigeminal Neuralgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-11-08FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia [NA]
This clinical trial update evaluates the effect of a surface acoustic wave patch device on the symptoms of trigeminal neuralgia. The current…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Hippocampal Radiation Exposure and Memory
A completed clinical trial evaluated whether hippocampal radiation exposure affects memory in patients with arteriovenous malformation, schw…
-
FDA label_change · 2016-06-17FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) to update the labeling language.
-
FDA label_change · 2015-08-28FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis, resulting in labeling changes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-05-13Clinical Trial Update: CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
A clinical trial evaluating routine postoperative lumbar taps to prevent CSF leaks after microvascular decompression has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia [NA]
An interventional randomized trial evaluating L-Baclofen in patients with refractory trigeminal neuralgia has completed. The snippet does no…
-
FDA approval · 2015-02-18FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for carbamazepine filed by Apotex Corp., indicating an approved modification to the generic prod…
-
FDA approval · 2015-01-20FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited, indicating an approved action on an existing…
-
FDA approval · 2015-01-20FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-09-16FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation. The action updat…
-
FDA approval · 2014-09-16FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol XR (carbamazepine) from Novartis Pharmaceuticals Corporation, resulting in updated labe…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia [NA]
This clinical trial update notes the completed status and posted results of an investigational drug studied in patients with trigeminal neur…
-
FDA approval · 2014-03-18FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
The FDA approved Apotex Corp.'s supplemental application for carbamazepine, a generic anticonvulsant. This action updates the approval statu…
-
FDA approval · 2014-03-10FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-02-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for carbamazepine, a generic anticonvulsant.
-
FDA approval · 2014-02-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited, indicating updated authorization for the…
-
FDA approval · 2014-01-16FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation. The action pertains to c…
-
FDA label_change · 2014-01-16FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis, leading to changes to the product labeling.
-
FDA approval · 2014-01-16FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol XR (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2013-11-08FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation. The approval updates…
-
FDA approval · 2013-11-08FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approves a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation, resulting in an upda…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: The Effect of Intravenous Lidocaine on Trigeminal Neuralgia [NA]
A completed clinical trial studied intravenous lidocaine for trigeminal neuralgia; the update notes completion but does not provide results …
-
FDA approval · 2013-07-29FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol XR (carbamazepine) by Novartis Pharmaceuticals Corporation, typically resulting in upda…
-
FDA approval · 2013-07-09FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for EPITOL (carbamazepine) filed by Teva Pharmaceuticals USA, Inc., under ANDA070541.